GlassScriptPhysician profile
Patrick G Sheehy
NPI 1699704015
$6,606.79
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,412 · 2020: $133 · 2021: $19.96 · 2022: $42.27.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $5,861.29 | 2019-2020 | |
| Abbott Laboratories | $190.27 | 2019-2022 | |
| Amgen INC. | $164.64 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $72.81 | 2019 | |
| Sanofi-Aventis U.S. LLC | $68.15 | 2019 | |
| Boston Scientific Corporation | $57.86 | 2019-2020 | |
| Cardiovascular Systems INC. | $33.93 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.91 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $25.31 | 2019-2020 | |
| Pfizer INC. | $23.09 | 2019-2020 | |
| Medtronic, INC. | $19.96 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $18.18 | 2019 | |
| Biocompatibles, INC. | $16.50 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.50 | 2019 | |
| Penumbra, INC. | $9.39 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Sheehy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.